UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
389.68
-22.34 (-5.42%)
At close: Nov 17, 2026, 4:00 PM EST
388.43
-1.25 (-0.32%)
After-hours: Nov 17, 2026, 7:59 PM EST

UnitedHealth Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
349,162329,489377,452245,608299,026312,729283,001479,081465,535539,904468,715456,081486,945467,034447,491440,854495,373472,406481,873479,830472,941
Market Cap Growth (YoY)
19.76%5.36%33.38%-48.73%-35.77%-42.08%-39.62%5.04%-4.40%15.60%4.74%3.45%-1.70%-1.14%-7.13%-8.12%4.74%28.22%27.52%36.42%42.14%
Enterprise Value
397,648381,734434,806311,835361,978373,386343,686545,495521,065598,591524,168508,252520,885500,613485,476488,517513,470507,492508,765513,450503,175

Price Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
22.2720.7426.7320.3924.8017.7813.2921.6732.3237.7133.24-21.7621.5421.2021.2924.6224.3126.4027.5027.36
PS Ratio
0.780.730.840.550.670.720.671.171.161.371.221.201.311.301.281.311.531.501.571.611.64
PB Ratio
3.563.123.562.332.942.962.704.564.545.174.724.714.924.974.864.875.745.705.946.186.18
P/FCF Ratio
15.3014.4415.9812.4918.6018.0011.2019.2722.4841.2375.5343.37-17.6711.7212.89-15.0823.5624.9723.78
P/OCF Ratio
13.3312.5813.9710.6115.1814.929.7716.8019.2332.4448.8332.85-15.7110.8211.85-13.9120.9622.1621.17

EV Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
EV/Sales Ratio
0.880.850.970.690.810.860.811.331.301.521.361.341.401.391.391.451.581.611.661.731.75
EV/EBITDA Ratio
13.7612.4715.3212.1914.0612.199.8314.4914.3216.5214.5514.0414.3414.0914.1614.7416.1316.7617.8618.8018.59
EV/EBIT Ratio
15.0914.4918.0514.6716.9314.1711.1816.3016.1418.5916.3715.7816.1015.8615.9216.5218.0618.7420.0821.2320.99
EV/FCF Ratio
17.4216.7218.4115.8622.5221.4913.6021.9425.1745.7184.4648.33-18.9412.7114.28-16.2024.8826.7225.30

Financial Efficiency

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Debt / Equity Ratio
0.700.700.690.740.820.760.760.770.750.750.760.760.630.670.710.780.670.590.630.610.60
Debt / EBITDA Ratio
2.442.432.031.944.813.703.182.002.182.002.112.061.801.661.811.951.831.471.621.531.82
Debt / FCF Ratio
3.263.263.113.965.164.613.133.273.715.9612.107.00-2.401.722.06-1.552.512.472.31
Net Debt / Equity Ratio
0.460.460.420.470.580.500.480.480.500.440.490.470.380.260.260.320.400.120.330.280.32
Net Debt / EBITDA Ratio
1.681.581.581.952.281.731.451.341.421.261.361.251.020.690.690.871.080.320.940.810.91
Net Debt / FCF Ratio
2.122.121.902.543.653.052.002.032.493.487.874.301.450.930.620.841.460.311.311.151.24
Quick Ratio
0.660.660.700.720.700.750.770.770.750.830.780.760.690.720.710.720.650.730.670.670.66
Current Ratio
0.740.740.780.800.790.820.850.850.830.910.850.820.750.770.760.770.730.780.730.740.73
Asset Turnover
1.431.431.461.451.471.421.421.381.401.361.361.341.431.371.371.331.421.381.391.401.41
Return on Equity (ROE)
15.77%15.77%14.15%12.18%12.54%17.48%21.65%22.70%15.13%15.25%15.58%17.22%24.98%25.30%25.07%25.27%25.35%25.29%24.25%24.15%24.12%
Return on Assets (ROA)
5.24%5.24%4.87%4.27%4.40%5.36%6.46%7.04%7.06%6.92%7.07%7.09%7.79%7.51%7.47%7.32%7.76%7.42%7.19%7.09%7.32%
Return on Invested Capital (ROIC)
12.39%11.88%11.02%9.75%9.88%11.84%14.27%15.24%-5668.75%-5687.87%-5820.67%-5826.05%16.85%17.17%16.47%16.17%16.72%16.89%15.84%15.91%16.11%

Yields

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Earnings Yield
4.49%4.82%3.74%4.90%4.03%5.62%7.52%4.61%3.09%2.65%3.01%3.37%4.60%4.64%4.72%4.70%4.06%4.11%3.79%3.64%3.65%
FCF Yield
6.54%6.93%6.26%8.01%5.38%5.56%8.93%5.19%4.45%2.43%1.32%2.31%5.27%5.66%8.54%7.76%4.72%6.63%4.24%4.00%4.21%
Dividend Yield
2.38%2.46%2.15%3.27%2.65%2.50%2.72%1.60%1.61%1.36%1.52%1.52%1.38%1.40%1.42%1.40%1.21%1.23%1.16%1.14%1.11%
Payout Ratio
53.04%50.56%38.06%31.93%20020.00%85.26%58.72%30.39%34.86%31.99%45.90%-31.86%29.77%31.91%27.39%32.37%29.30%30.47%27.11%33.53%
Buyback Yield / Dilution
0.98%0.66%0.44%0.87%1.83%2.37%1.94%0.43%0.86%0.64%1.28%2.23%1.27%1.27%1.05%1.15%0.84%0.73%0.63%0.31%0.62%
Total Shareholder Return
3.36%3.13%2.59%4.14%4.48%4.86%4.66%2.03%2.46%2.00%2.80%3.74%2.65%2.66%2.47%2.55%2.04%1.96%1.79%1.45%1.74%
SEC Filings: 10-K · 10-Q